Abbott Laboratories (ABT) stock
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3034% above fair value
$104.71−2.74 (-2.55%)
Close on Nov 17, 2026Market cap $181.19BP/E 33.7Yield 2.29%
Abbott Laboratories market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Abbott Laboratories's market cap was $190.82B on Nov 11, 2026, against $225.29B a year earlier. Over the last 5 years it ranged from $149.62B to $252.07B, with a median of $194.87B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $190.82B | -12.9% |
| 2025 | Dec 31, 2025 | $218.98B | +10.7% |
| 2024 | Dec 31, 2024 | $197.78B | +2.6% |
| 2023 | Dec 29, 2023 | $192.70B | -0.9% |
| 2022 | Dec 30, 2022 | $194.49B | -22.8% |
| 2021 | Dec 31, 2021 | $252.07B | +29.1% |
| 2020 | Dec 31, 2020 | $195.30B | +26.4% |
| 2019 | Dec 31, 2019 | $154.52B | +21.0% |
| 2018 | Dec 31, 2018 | $127.72B | +33.2% |
| 2017 | Dec 29, 2017 | $95.91B | +68.2% |
| 2016 | Dec 30, 2016 | $57.01B | -16.0% |
| 2015 | Dec 31, 2015 | $67.89B | -1.9% |
| 2014 | Dec 31, 2014 | $69.23B | +14.2% |
| 2013 | Dec 31, 2013 | $60.60B | -41.7% |
| 2012 | Dec 31, 2012 | $103.95B | +18.3% |
| 2011 | Dec 30, 2011 | $87.85B | +17.8% |
| 2010 | Dec 31, 2010 | $74.59B | -11.2% |
| 2009 | Dec 31, 2009 | $84.00B | – |
See a number that looks wrong?